Skip to Content

Arkema SA

AKE: XPAR (FRA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€329.00FmbcRsfxxvqxc

Arkema Earnings: In-Line EBITDA Delivery; Market Conditions Remain Challenging in 2024

No-moat Arkema delivered 2023 EBITDA of EUR 1.5 billion, in line with company-compiled consensus and our estimates. This represents a 29% decline from a high 2022 comparison base, driven by soft demand across most end markets and customer destocking measures. For 2024, management targets EBITDA of EUR 1.5 billion to EUR 1.7 billion—a broad range given uncertainty over the timing of demand recovery, which is expected to remain soft in the first quarter. We don’t expect to make a material change to our EUR 105 fair value estimate after incorporating these results and view shares as fairly valued at current levels.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of AKE so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center